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Abstract The aim of this study was
to test the efficacy of four different
radio-frequency ablation (RFA) sys-
tems in normal hepatic parenchyma
in large animals. The RFA was ap-
plied to pig livers in vivo and to calf
livers ex vivo using the Radionics
cluster needle, RITA starburst XL
needle, Radiotherapeutics Le Veen
4.0 needle, and the Berchtold 14-G
saline-perfused 15-mm active-tip
needle based on constructor specifi-
cations. The volume of tissue coagu-
lation from RF was calculated from
measurements of the vertical diame-
ter (Dv) and transverse diameter
(Dt). Lesion shape was characterized
using the ratio between Dt/Dv. Ra-
diotherapeutics and RITA produced
in vivo lesion volume of 42±10,
39±4 cm3 with a reproducible spheri-
cal shape (Dt/Dv of 1.01±0.16 and
0.97±0.1, respectively). Radionics
produced in vivo RF lesions volume
of 29±11 cm3 with an ovoid shape
(Dt/Dv 0.88±0.09). The RF lesions
with the Berchtold device could not
be assessed in vivo as 5 of 8 animals
died during treatment. Ex vivo RF
lesions had similar volumes with
each system; however, the Radio-
therapeutics device produced more
reproducible shaped lesions than the
other systems. In our experimental
study, we found no difference be-
tween expandable needle systems in
vivo. Cooled needles produced
slightly smaller and ovoid shape in
vivo lesions.
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Introduction
Image-guided tumor ablation has become increasingly
popular in recent years. While various percutaneous 
ablative techniques currently exist for the treatment of
selected patients with hepatic malignancy, RFA is cur-
rently the most widely used technique [1]. To perform
RFA, a needle electrode is inserted into the tumor under
imaging guidance. This probe emits alternative current
with frequencies ranging from 450 to 500 KHz that in-
duce ionic agitation, thus producing heat. At tempera-
tures above 60°C, cells die instantly from protein coagu-
lation and dehydration.
The first RF needle electrodes available produced
small volumes of necrosis with destruction in the liver
limited to the maximal diameter perpendicular to the
needle axis less than 1.6 cm after a single focus of RF
delivery [2]. For this reason, complete tumor destruction
usually necessitated multiple, overlapping RF deliveries,
limiting the use of this technique. To avoid this problem,
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ton, Mass.), Radiotherapeutics (Sunnyvale, Calif.), and RITA
(Mountain View, Calif.; Fig. 1). Lesions were created according to
specific protocols defined by each of the four RF manufacturers
with regard to their own RF device. The systems were operated
during the experiment by experts experienced in running the ma-
chines who were chosen by each company.
For this study, a Berchtold Elektrotom 60 W 106 HITT device
was used in association with a 14-G single needle electrode. The
needle has an exposed tip 15 mm long in which there are three
groups of two side holes each, placed at 120° angle from each oth-
er. The needle was connected to an infusing pump that was set to
deliver 100 ml/h of normal saline at room temperature through the
needle side holes. Care was taken to begin the infusion immediate-
ly prior to the liver puncture in order to avoid obstruction of the
needle electrode side holes during placement. According to com-
pany recommendations, three separate 5-min RF deliveries (total
RF time: 15 min) with a power of 50 W was performed at each
needle position. Between each 5-min RF delivery, the RF was
turned off for 2-min intervals.
The Radionics RF system used for this study was a 3CC1 Rad-
ionics generator that produces a maximum power of 200 W
through a 17-G triple cluster-cooled needle electrode. The triple
cluster needle is composed of three parallel 2.5-cm active-cooled
needles spaced 0.5 cm apart and arranged in a triangular pattern.
Needle cooling is ensured by peristaltic perfusion of chilled saline,
which allows the electrode to maintain tip temperatures below
25°C during RF delivery. The generator was used in the auto-con-
trol mode generating a pulsed RF delivery for 15 min for each
needle position. The auto-control mode allowed for the maximum
power to be delivered until the impedance rose to 10 Ω above the
baseline value. When the current reached this level, it was auto-
matically switched off for 15 s; thereafter, it was switched on
again generating pulsed RF known to increase size of lesions [9].
The Radiotherapeutics RF system used for these procedures in-
cluded a Radiotherapeutics RF3000 generator with a maximal
200-W power output that was linked to a 4-cm Le Veen needle.
Following deployment within the liver, we used the recommended
algorithm that started with a RF power of 80 W that was further
increased by 10 W per minute up to 130 W. After 10 min, if im-
pedance had not increased, the RF power was again increased by
10-W installments. The procedure was terminated when a marked
increase in impedance, called “roll off,” occurred.
The RITA RF system chosen for the experiment was the RITA
RF model 1500 combined with 14-G Starburst XL needles. The
needle was flushed before puncture by injecting saline through the
lateral hub. After adequate needle positioning within the liver, the
prongs were first deployed at 2-cm length with the power set at
50 W until a temperature of 80°C was reached. Subsequently, the
prongs were advanced forward until they were deployed at 3 cm.
At this length, a power of 70 W was used until a temperature of
105°C was reached. After further deployment of 4 cm, the energy
was set at 90 W until reaching 110°C. Finally, after 5-cm deploy-
ment, RF energy was set at 110 W until a mean temperature of
110°C was reached and maintained for 7 min. The generator was
then turned off. If a temperature of 70°C was maintained for at
least 30 s after switch off, the procedure was considered complet-
ed. If this temperature was not maintained, an additional 5-min RF
delivery was performed with the temperature maintained at 110°.
In addition, if the temperature of one prong remained low, the
prongs were pulled back into pre-deployment position, rotated by
45°, then deployed again. Careful attention was paid during de-
ployment to avoid pulling back of the needle.
Statistical evaluation
The volume of tissue destruction obtained by RF was evaluated by
approximating the lesion to a sphere using the following formula:
π(DvxDtxDt)/6. Because only one transverse diameter Dt to the
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needle electrodes have been optimized in different ways,
i.e., expandable needles, cooled cluster needle, saline 
enhanced or wet electrode, and some combined forms
such as cooled-wet or expandable-wet electrodes, in an
attempt to increase the area of tissue destruction ob-
tained with one RF delivery [3, 4, 5, 6, 7, 8, 9, 10, 11].
Furthermore, the control of RF delivery according to im-
pedance, time, and/or temperature is different from one
system to another.
The purpose of this study was to compare the efficacy
in normal liver parenchyma in vivo and ex vivo of four
commercially available RF delivery systems (needle and
generator; time of study: from June to November 2001)
from Bertchtold (Tuttlingen, Germany), Radionics 
(Burlington, Mass.), Radiotherapeutics (Sunnyvale, 
Calif.), and RITA (Mountain View, Calif.). The RF pro-
tocols of energy deposits were made according to manu-
facturers’ specifications.
Materials and methods
Study design
Experiments were performed in the interventional radiology 
research center of the national center for agronomic research.
Large White Swine weighing between 80 and 100 kg were used in
accordance with legislation governing animal care. After pre-med-
ication with Ketamine, 21 animals were intubated and anesthe-
tized with methoxyflurane (1–2%). Cardiac and respiratory param-
eters were monitored and maintained throughout the procedures.
After careful skin preparation, grounding pads were placed on the
thigh according to manufacturer’s specifications. Median lapar-
otomies with intra-operative ultrasound guidance (7.5-MHz probe)
were performed in all animals to allow for precise positioning of
the RF electrodes. The RF electrodes were placed by one of the
two investigators (A.D. or T.D.B.), into the thicker portion of the
liver and away from large vessels, as previously described [3].
Due to the relatively large size of the RF lesions produced when
compared with the remainder of the liver, only one to three lesions
could be created per animal liver. Radio-frequency units and the
order in which each lesion was produced were randomly assigned.
The animals were killed and the livers harvested immediately
after the experiments. Specimens were cut along the needle axis
into 5-mm-thick slices. The RF areas of destruction were mea-
sured in two perpendicular directions, one along the needle axis
called vertical diameter (Dv) and the other perpendicular to it
called transverse diameter (Dt) These measurements were per-
formed in consensus of two investigators (A.D., T.D.B.). Macro-
scopic changes in specimens have been demonstrated to correlate
well with coagulation necrosis at histopathological examination [2].
The ex vivo study was conducted on explanted calf livers at
room temperature. One grounding pad was positioned more than
20 cm away from the distal tip of the RF electrode. The tip of the
needle electrode was at least 5 cm deep within the liver parenchy-
ma (lesions were created for each system, 5–8 lesions were creat-
ed in each calf liver). Lesion size measurements were performed
in the same manner as in the in vivo experiment.
Protocols of RF delivery
Four RF systems were evaluated during this study which included
Bertchtold Elektrotom (Tuttlingen, Germany), Radionics (Burling-
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electrode could be measured, we used it twice in the formula as-
suming that the second transverse diameter measurement was sim-
ilar to the first. Volume differences of in vivo lesions obtained
with the multiple RF systems were compared using a one-way
analysis of variance (ANOVA) test followed by an unpaired 
Student’s t test for group to group comparison. The same statisti-
cal evaluation was applied for ex vivo lesions. Lesion variability
was compared between groups using crossed variance component
analysis by F test of variance. Evaluation of the volume variation
in each group was given by a variation coefficient calculated as
follows: standard deviation/mean value.
Radio-frequency lesion shape was characterized by the ratio
between the transverse and vertical diameter Dt/Dv. This ratio was
compared between groups using one way ANOVA test, unpaired
t test was used for group-to-group comparison. Variability was
compared between groups using crossed variance component anal-
ysis by F test of variance. Evaluation of the variation of volume in
each group was given by a variation coefficient calculated as fol-
lows: standard deviation/mean value. Statistics were performed
using the JMP statistical software (Statistical package 4.0, SAS 
Institute, Cary, N.C.)
Results
In vivo RF lesions
A total of 27 lesions could be completed in 21 pigs.
Eight lesions each were created with the Radionics, Ra-
diotherapeutics, and RITA systems. In three cases, when
using the RITA device, the target temperature could not
be reached in one of the thermocouples. This was
thought to be due a large vessel in the vicinity of this ar-
ray; therefore, the needle was re-deployed after a 45° ro-
tation of the device. No complications were observed us-
ing Radionics, RITA, and Radiotherapeutics system.
Regarding RF delivery time, RFA lesion creation took
15 min for Radionics and 19 min for Berchtold. The
Fig. 1a–d Radio-frequency systems tested. a The tip of the RITA
14G Starburst XL needle tested with nine prongs deployed at the
extremity. b The Radionics cooled-tip triple-cluster needle and
single cooled-tip needle. c The Radiotherapeutics 4 cm Le Veen
needle. d The Berchtold needle tips with side holes at the needle
extremity
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mean RF delivery times for Radiotherapeutics was
17 min (standard deviation 2.2 min, range 12–20 min)
and 25 min for RITA lesions (standard deviation 3.4 min,
range 15–32 min).
With the Bertchtold system, only three lesions could
be completed as 5 of 8 animals used with this unit died
during the RF delivery. Analysis of RFA lesions in the 5
dead animals showed extension of the tissue coagulation
along the vascular (portal or hepatic venous) pedicles
(Fig. 2) with fresh clots in the hepatic veins in two cases.
Because of this, RFA lesions created with this system did
not allow for statistical analysis. Furthermore, one lesion
created with the Berchtold system had extensive coagu-
lation diffusing along the liver capsule (Fig. 3).
Lesions volumes obtained with RITA, Radiotherapeu-
tics, and Radionics, were 39±4.3, 42±10, and 29±11 cm3,
respectively (Table 1). Statistical differences were ob-
served between these three groups using ANOVA test
(p<0.05). Group-by-group statistical comparison demon-
strated statistical differences between Radiotherapeutics
and Radionics (p<0.05) and nearly significant difference
between RITA and Radionics (p=0.056). No statistical
difference existed when RITA was compared with Ra-
diotherapeutics using an unpaired t test. F test analysis of
variance found significant differences in variance be-
tween RITA, Radiotherapeutics, and Radionics (p<0.05).
Transverse diameter was statistically significantly differ-
ent between RITA and Radiotherapeutics (4.15±0.23 and
4.3±0.5 cm, respectively) and Radionics (3.62±0.41;
p<0.05).
The Dt/Dv ratio for Radiotherapeutics and RITA RF
systems were 1.01±0.16 and 0.97±0.1, respectively, cor-
responding to near spherical shapes of the volume of co-
agulation (Fig. 4). More elongated lesions were demon-
strated by Radionics and Bertchtold RF systems with
Dt/Dvratios of 0.88±0.09 and 0.65±0.39, respectively.
There was not significant difference and there was not
significant variance of Dv/Dt ratio using F test.
Fig. 2a, b Radio-frequency (RF) in vivo lesions created with the
Berchtold system. a The RF lesion extending along the hepatic
vein wall away from the RF lesion with fresh clots inside of the
vein. b Another Berchtold in vivo lesion showing coagulation fol-
lowing vascular branches away from the RF lesion
Fig. 3a, b The RF in vivo lesion created with the Berchtold
system. a The anterior aspect of the liver shows a large lesions ex-
tended all along the liver surface. b The liver shows this ovoid le-
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Ex vivo RF lesions
Thirty-two lesions could be performed in explanted calf
liver (8 lesions for each system) Ex vivo lesion volumes
ranged between 55 and 68 cm3 without statistical differ-
ences found between the four devices using the ANOVA
test and Student’s t test (Table 2). Variation coefficients
were also greater for lesion volume in ex vivo lesions as
compared with in vivo lesions. Comparison of variance
between groups of ex vivo lesion volume did not show
any statistical significance, whereas comparison of vari-
ance of the Dv/Dt ratio in the same groups was highly
significant (p<0.00000001).
Discussion
Percutaneous RF tumor ablation has gained significant
popularity during recent years. In particular, RFA has
been advocated by many physicians as a primary treat-
ment for selected patients with hepatocellular carcinoma.
Recent reports have demonstrated that RFA is more effi-
cacious than percutaneous ethanol injection (PEI) allow-
ing for equivalent tumor control in fewer treatment ses-
sions [14]; however, one limitation of this therapy is the
size of RF lesions that can be obtained with one RF de-
livery. Although the efficacy of RFA is close to 100% for
tumors less than 2 cm in diameter, the local recurrence
rates are ≥20% for tumors larger than 2.5 or 3 cm, and
≥50% for lesions larger than 5 cm [10]. In the same way,
destruction of a lesion of 2 cm in size with a 1-cm safety
margin corresponds to a RFA size in volume of
33.49 cm3. For a larger lesion of 3 cm in diameter with
the same 1-cm safety margin, this RFA volume should
be 65.42 cm3. In our study the technological improve-
ments allowed a theoretical destruction of lesions be-
tween 2 and 3 cm in diameter. One must consider that
these improvements are important, but they are still far
from what we may expect from a clinical point of view.
New experimental developments recently demonstrated
in experimental studies, such as combined wet cooled or
wet expandable, may further improve RFA lesion size [9,
10, 11].
Both RITA and Radiotherapeutics developed multi-
probe needles that are able to deploy nine (Christmas-
tree shaped) or ten (umbrella shaped) prongs, respective-
ly. In our experimental study, these two systems provid-
ed the largest volume of tissue destruction. In addition,
these systems created near-spherical lesions in vivo with
Table 1 Mean volume of radio-frequency ablation (RFA) lesions created in pig liver in vivo
Bertchtod Radionics Radiotherapeutics RITA
Number 3 8 8 8
Mean volume (cm3)±SD 37±8 29±11 42±10 39±4.3
Volume variation coefficient (%) 22 37 24 11
Vertical diameter Dv (cm) 6.4±1.9 4.16±0.6 4.29±0.43 4.3±0.29
Transverse diameter W (cm) 3.4±0.75 3.62±0.41 4.3±0.5 4.15±0.23
Dt/Dv ratio±SD 0.65±0.39 0.88±0.09 1.01±0.16 0.97±0.1
Dt/Dv variation coefficient (%) 60 11 16 11
Fig. 4 The cut liver shows a 4.7-cm almost spherical in vivo le-
sion created with the RITA system
Table 2 Mean volume and di-
ameter ratio of ex vivo RFA le-
sions
Bertchtold Radionics Radiotherapeutics RITA
Number 8 8 8 8
Mean volume (cm3)±SD 67±24 66±20 55±13 68±20
Volume variation coefficient (%) 35 31 24 29
Vertical diameter Dv (cm) 5.42±1.2 5.56±0.72 4.35±0.34 5.94±0.62
Transverse diameter Dt (cm) 4.63±0.62 4.69±0.44 4.48±0.47 4.61±0.45
Dt/Dv ratio±SD 0.89±0.16 0.84±0.06 1.12±0.08 0.78±0.03
Dt/Dv variation coefficient (%) 18 7 6 4
(W/L) ratios of transverse to needle axis close to 1. This
finding is important for local tumor treatment as most
hepatic tumors have a spherical shape. We did not 
observe any difference in terms of RF lesion volume 
between these two devices; however, repositioning of the
needle was necessary in 3 cases with the RITA device,
increasing the lesion creation time. The RITA RF system
monitors intra-lesional temperature with five thermocou-
ples. When a needle is positioned close to a vessel, the
temperature does not increase in this area. As a conse-
quence, the needle position can be modified to avoid this
limitation. This may explain, in part, the reproducible
volumes obtained with this device as compared with the
Radiotherapeutics system which monitors treatment with
an impedance control mechanism.
Another strategy that can be used to increase RF 
lesion size is to minimize carbonization (“charring”) of
tissue around needle tip. This can be done through a con-
tinuous perfusion of cold saline within the needle lumen
as proposed by Radionics; however, our study shows that
in vivo lesions produced by Radionics were slightly
smaller and more ovoid in shape than the lesions pro-
duced by RITA or Radiotherapeutics devices.
Bertchtold applies another concept to increase lesion
size with RF. Isotonic saline can be infused into the tis-
sue through holes at the extremity of the needle, thereby
increasing electrical conductivity in the needle vincinity
[10]. The protocol used in our investigation and recom-
mended by the Berchtold company killed 5 of 8 animals
within the first 3 min of RF delivery with perfusion. At
present, we have no definite explanation for these
deaths; however, livers removed from 4 of the 8 pigs
treated with this device show coagulation running along
the large hepatic veins and away from the RF lesion.
This finding suggested diffusion of the heated saline
along the outside wall of these veins. Moreover, in 2
cases, clots were found in the hepatic veins. For this rea-
son, we considered pulmonary embolism as a possible
explanation for their deaths; however, in clinical series,
such complications have never been reported, to our
knowledge in the literature [11]; however, the shape of
the lesions were irregular as previously observed [12,
13].
Our study supports the recent finding of Goldberg et
al. who evaluated the consequences of hyperosmolar sa-
line injection [14], mentioning that shape of lesions were
irregular and hardly predictable, especially when large
amounts of saline (>25 ml) were injected. In our study, a
total amount of 25 ml was used as recommended by the
manufacturer. This large amount of saline may explain
for spread of coagulation distally to the RF lesions along
the vascular bed or under the capsule.
This study also demonstrates that using ex vivo com-
parisons of RF systems brings no significant valuable in-
formation to the in vivo efficacy of these systems. In-
deed, despite statistical differences that were observed in
vivo, no differences were observed ex vivo. Moreover,
the variation coefficients of RF lesion volumes were
higher for ex vivo than for in vivo lesions for RITA and
Radiotherapeutics systems.
This study does have some limitations. Firstly, it is
not known whether the results of this animal liver model
accurately predict the results of treating liver tumors in
patients [15]. Differences in tissue vascularization, im-
pedance, and heterogeneity in tumors may modify the re-
sults that we observed. Secondly, we have no definite ex-
planation for the deaths of 5 animals using Bertchtold
device. We hypothesized that the deaths were due to
massive pulmonary emboli on the basis of hepatic vascu-
lar thrombosis. Since that hypothesis was retrospectively
supposed on the basis of liver pathological studies, we
did not take the opportunity to check the lung at autopsy.
This complication has never been described in human
studies with this unit; however, literature regarding use
of the device is limited. Thirdly, we did not use the most
recent expandable needles developed by RITA and Ra-
diotherapeutics (Starburst Xli and Le Veen 6.0, respec-
tively) since they were not yet available. Fourth is the
size of pig liver. Even when using the largest pigs avail-
able in our institute, the thickness of the livers rarely ex-
ceeded 6 cm due to their leafy anatomy. For this reason,
it was possible to perform only one to three RF lesions
per animal resulting in the relatively low number of le-
sions in our study. Fifthly, systems were run according to
each manufacturer’s specifications. Their recommenda-
tions may or may not have represented the greatest de-
gree of optimization possible. Superiority of one system
over another only reflects the situation in the experimen-
tal conditions described at the moment of the study. This
may rapidly change in the future due to new needle or
protocol improvements.
Conclusion
In this experimental study, we did not observe differ-
ences between expandable needles systems in vivo.
Cooled needles produced slightly smaller lesions with a
more ovoid shape. Improvements in needles and delivery
protocols are still mandatory to treat with safety margins
tumors larger than 3 cm in diameter.
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